Tice Matthew J L, Bailey Stacyann, Sroga Grażyna E, Gallagher Emily J, Vashishth Deepak
Department of Biomedical Engineering Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute New York NY USA.
Division of Endocrinology, Diabetes and Bone Diseases, Department of Medicine Icahn School of Medicine at Mount Sinai New York NY USA.
JBMR Plus. 2021 Dec 16;6(2):e10583. doi: 10.1002/jbm4.10583. eCollection 2022 Feb.
Obesity is a common comorbidity of type 2 diabetes (T2D). Therefore, increased risk of fragility fractures in T2D is often confounded by the effects of obesity. This study was conducted to elucidate the mechanistic basis by which T2D alone leads to skeletal fragility. We hypothesized that obesity independent T2D would deteriorate bone's material quality by accumulating defects in the mineral matrix and undesired modifications in its organic matrix associated with increased oxidative stress and hyperglycemia. To test this hypothesis, we used 15-week-old male non-obese mice with engineered muscle creatine kinase promoter/human dominant negative insulin growth factor 1 (IGF-I) receptor (MKR) and FVB/N wild-type (WT) controls ( = 12/group). MKR mice exhibit reduced insulin production and loss of glycemic control leading to diabetic hyperglycemia, verified by fasting blood glucose measurements (>250 mg/dL), without an increase in body weight. MKR mice showed a significant decrease in femoral radial geometry (cortical area, moment of inertia, cortical thickness, endosteal diameter, and periosteal diameter). Bone mineral density (BMD), as assessed by micro-computed tomography (μCT), remained unchanged; however, the quality of bone mineral was altered. In contrast to controls, MKR mice had significantly increased hydroxyapatite crystal thickness, measured by small-angle X-ray scattering, and elongated -axis length of the crystals evaluated by confocal Raman spectroscopy. There was an increase in changes in the organic matrix of MKR mice, associated with enhanced glycoxidation (carboxymethyl-lysine [CML] and pentosidine) and overall glycation (fluorescent advanced glycation end products), both of which were associated with various measures of bone fragility. Moreover, increased CML formation positively correlated with elongated mineral crystal length, supporting the role of this negatively charged side chain to attract calcium ions, promote growth of hydroxyapatite, and build a physical link between mineral and collagen. Collectively, our results show, for the first time, changes in bone matrix in a non-obese T2D model in which skeletal fragility is attributable to alterations in the mineral quality and undesired organic matrix modifications. © 2021 The Authors. published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
肥胖是2型糖尿病(T2D)的常见合并症。因此,T2D中脆性骨折风险的增加常常因肥胖的影响而混淆。本研究旨在阐明T2D单独导致骨骼脆弱的机制基础。我们假设,独立于肥胖的T2D会通过在矿物质基质中积累缺陷以及在其有机基质中产生与氧化应激增加和高血糖相关的不良修饰,从而使骨骼材料质量下降。为了验证这一假设,我们使用了15周龄的雄性非肥胖小鼠,这些小鼠经过基因工程改造,带有肌肉肌酸激酶启动子/人显性负性胰岛素生长因子1(IGF-I)受体(MKR),并以FVB/N野生型(WT)小鼠作为对照(每组n = 12)。MKR小鼠胰岛素分泌减少且血糖控制受损,导致糖尿病性高血糖,空腹血糖测量结果证实了这一点(>250mg/dL),但其体重并未增加。MKR小鼠的股骨径向几何结构(皮质面积、惯性矩、皮质厚度、骨内膜直径和骨膜直径)显著减小。通过微计算机断层扫描(μCT)评估的骨矿物质密度(BMD)保持不变;然而,骨矿物质的质量发生了改变。与对照组相比,通过小角X射线散射测量,MKR小鼠的羟基磷灰石晶体厚度显著增加,通过共聚焦拉曼光谱评估,晶体的长轴长度也有所延长。MKR小鼠有机基质的变化增加,与糖氧化增强(羧甲基赖氨酸[CML]和戊糖苷)和整体糖基化(荧光晚期糖基化终产物)有关,这两者都与多种骨骼脆性指标相关。此外,CML形成的增加与矿物质晶体长度的延长呈正相关,支持了这种带负电荷的侧链吸引钙离子、促进羟基磷灰石生长以及在矿物质和胶原蛋白之间建立物理联系的作用。总体而言,我们的结果首次表明,在非肥胖T型糖尿病模型中,骨骼基质发生了变化,其中骨骼脆性归因于矿物质质量的改变和有机基质的不良修饰。© 2021作者。由Wiley Periodicals LLC代表美国骨与矿物质研究学会出版。